Use of Glucagon-Like Peptide-1 Receptor Agonists Around the Time of Surgery

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be associated with an increased risk of pulmonary aspiration due to drug-induced gastroparesis.

• GLP-1 RAs are becoming significant in treating Type 2 Diabetes Mellitus and obesity.
• Concerns have been raised regarding the potential for pulmonary aspiration in patients using these medications.
• The link between GLP-1 RAs and pulmonary aspiration is not definitively established.
• Current evidence suggests a need for cautious management of patients on GLP-1 RAs.

Simplified